Annual out-of-pocket treatment costs for multiple sclerosis increased by 125% from 2002 to 2021 in the US, driven mainly by ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
The development of treatment for multiple sclerosis over the past 25 years is a success of translational medicine. In this Timeline article, Tintore et al. chart major developments and discuss the ...
Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Lymph node-like ...
News-Medical.Net on MSN
Periodontal bacterial load associated with disease severity in multiple sclerosis
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback